1. Home
  2. SONM vs TENX Comparison

SONM vs TENX Comparison

Compare SONM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • TENX
  • Stock Information
  • Founded
  • SONM 1999
  • TENX 1967
  • Country
  • SONM United States
  • TENX United States
  • Employees
  • SONM N/A
  • TENX N/A
  • Industry
  • SONM Telecommunications Equipment
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • TENX Health Care
  • Exchange
  • SONM Nasdaq
  • TENX Nasdaq
  • Market Cap
  • SONM 16.7M
  • TENX 19.5M
  • IPO Year
  • SONM 2019
  • TENX N/A
  • Fundamental
  • Price
  • SONM $3.19
  • TENX $6.59
  • Analyst Decision
  • SONM
  • TENX Strong Buy
  • Analyst Count
  • SONM 0
  • TENX 4
  • Target Price
  • SONM N/A
  • TENX $20.67
  • AVG Volume (30 Days)
  • SONM 32.7K
  • TENX 59.5K
  • Earning Date
  • SONM 11-13-2024
  • TENX 11-13-2024
  • Dividend Yield
  • SONM N/A
  • TENX N/A
  • EPS Growth
  • SONM N/A
  • TENX N/A
  • EPS
  • SONM N/A
  • TENX N/A
  • Revenue
  • SONM $56,744,000.00
  • TENX N/A
  • Revenue This Year
  • SONM N/A
  • TENX N/A
  • Revenue Next Year
  • SONM $107.78
  • TENX N/A
  • P/E Ratio
  • SONM N/A
  • TENX N/A
  • Revenue Growth
  • SONM N/A
  • TENX N/A
  • 52 Week Low
  • SONM $2.32
  • TENX $2.77
  • 52 Week High
  • SONM $10.70
  • TENX $26.40
  • Technical
  • Relative Strength Index (RSI)
  • SONM 41.47
  • TENX 69.89
  • Support Level
  • SONM $3.00
  • TENX $5.44
  • Resistance Level
  • SONM $3.76
  • TENX $5.78
  • Average True Range (ATR)
  • SONM 0.35
  • TENX 0.32
  • MACD
  • SONM -0.06
  • TENX 0.01
  • Stochastic Oscillator
  • SONM 9.11
  • TENX 83.85

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: